|
||||||||||||||||||||||||
|
![]() |
![]() |
![]() |
|
||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||
| |
||||||||||||||||||||||||
|
PRESS |
PRESS RELEASES
e(ye)BRAIN most recent press releases October 9th, 2012 EyeBrain raises 3.3 million euros in a second funding round. Three new investors, Octalfa, Sudinnova and CM-CIC Capital Innovation, have joined existing shareholders CapDecisif Management and G1JIDF. EyeBrain plans to use the funds to build up its sales force, while pursuing its existing R&D programs.
Read the press release. Jully 12th, 2012 EyeBrain sets up shop in the Brain and Spine Institute (ICM) to conduct its clinical research activities. EyeBrain is the first firm to benefit from the logistical facilities that the institute offers to companies collaborating with its research teams to encourage scientific exchange.
Read the press release. January 16th, 2012
EyeBrain’s medical device can now help diagnose and monitor disease development in multiple sclerosis patients. The latest version of the Eyebrain Tracker software incorporates specific analyses that accurately quantify the eye motricity anomalies associated with multiple sclerosis
Read the press release.
December 6th, 2011 EyeBrain announces that its EyeBrain Tracker device is being used in a clinical trial exploring the dyskinesia induced by treating patients suffering from idiopathic Parkinson’s disease with levodopa. The trial is being sponsored and financed by Bordeaux University Hospital and was set up by Professor Jean-François Tison, a neurologist attached to the CNRS Physiopathology of Parkinsonian syndromes unit at the University of Bordeaux 2 (the Institute of Neurodegenerative Diseases, CNRS UMR 5293E, Bezard).
Read the press release. March 14th, 2011 e(ye)BRAIN appoints business developer for Northern Europe. Read press release. January 25th, 2011 e(ye)BRAIN announces availability of its eye-tracking device for earlier diagnosis of Parkinson-plus diseases. Read press release. February 5th, 2010 G1J Ile-de-France, a pre-startup fund created at Genopole in 1999, contributes to e(ye)BRAIN's capital. See press realease (in French). November 18th, 2009
e(ye)BRAIN receives an initial startup investment from CapDécisif Management.
See press release (in French). |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||